Samenvatting
Een zeven dagen oude neonaat, zoon van Turkse consanguïene ouders, presenteerde zich met een opvallende afwezigheid van subcutaan vetweefsel. Hij had hepatomegalie, hyperglykemie, insulineresistentie, hypertriglyceridemie en een onmeetbaar laag leptine. De diagnose congenitale gegeneraliseerde lipodystrofie (CGL) ook berardinelli-seip-syndroom genoemd, werd gesteld. Een nieuwe mutatie in het seipine-gen werd gevonden. De behandeling bestaat uit een zeer sterk vetbeperkt dieet en bloedsuikerverlagende medicijnen.
Summary
A seven days old male child of consanguineous Turkish parents presented with a prominent lack of subcutaneous adipose tissue. He had hepatomegaly, hyperglycemia, insulin resistance, high serum triglyceride concentrations and an immeasurable serum leptin concentration. The diagnosis of congenital generalized lipodystrophy (CGL) also known as Berardinelli-Seip syndrome was made. A new mutation in the seipin gene was found. Treatment consisted in a low fat diet and insulin.
Literatuur
Garg A. Lipodystrophies. Am J Med. 2000;108:143–52.
Agarwal AK, Garg A. Genetic basis of lipodystrophies and management of metabolic complications. Annu Rev Med. 2006;57:297–311.
Hegele RA, Joy TR, Al-Attar SA, Rutt BK. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res. 2007;48:1433–44.
Magré J, Delépine M, Khallouf E, et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 2001;28:365–70.
Agarwal AK, Arioglu E, De Almeida S, et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet. 2002;31:21–3.
Szymanski KM, Binns D, Bartz R, et al. The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology. Proc Natl Acad Sci. 2007;104:20890–5.
Kim CA, Delepine M, Boutet E, et al. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab. 2008;93:1129–34.
Gorden P, Gavrilova O. The clinical uses of leptin. Curr Opin Pharmacol. 2003;3:655–9.
Agarwal AK, Simha V, Oral EA, et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab. 2003; 88:4840–7.
Beltrand J, Beregszaszi M, Chevenne D, et al. Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip lipoatrophy. Pediatrics. 2007;120: e291–6.
Van Maldergem L, Magre J, Khallouf TE, et al. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet. 2002;39:722–33.
Seip M, Trygstad O. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl. 1996;413:2–28.
Gezondheidsraad. Voedingsnormen: energie, eiwitten, vetten en verteerbare koolhydraten. Den Haag: Gezondheidsraad, 2001.
Oral EA, Simha V, Ruiz E, et al. Leptinreplacement therapy for lipodystrophy. N Engl J Med. 2002;346:570–8.
Javor ED, Cochran EK, Musso C, et al. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes. 2005;54:1994–2002.
Author information
Authors and Affiliations
Additional information
arts-assistent kindergeneeskunde, diëtist, kinderarts-endocrinoloog
Correspondentieadres: Dr. M.A.M.J. de Vroede, Wilhelmina Kinderziekenhuis, Postbus 85090, 3508 AB Utrecht
Rights and permissions
About this article
Cite this article
Beijer, P., van den Hurk, T., de Vroede, M. et al. Een zuigeling zonder subcutaan vet: berardinelli-seip-syndroom. TIJDSCHR. KINDERGENEESKUNDE 78, 33–36 (2010). https://doi.org/10.1007/s12456-010-0009-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12456-010-0009-0